Wegovy 1.7mg Click Chart vs Mounjaro: Understanding Your Options
When comparing Wegovy 1.7mg click chart information with Mounjaro equivalents, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors for dual hormone pathway activation. At the 1.7mg Wegovy stage—weeks 13 to 16 of treatment—you're approaching the penultimate dose before reaching maintenance, whereas Mounjaro follows a different escalation schedule starting at 2.5mg and progressing through six dose levels up to 15mg.
The Wegovy 1.7mg click chart represents a critical juncture where many patients experience accelerated results as their appetite regulation stabilises. Mounjaro's equivalent therapeutic stage occurs around the 7.5mg dose, typically reached after 8-12 weeks of treatment. Both medications require prescription-only access through clinical assessment, and EverydayMeds' GPhC-registered pharmacy (#9012878) provides both options with expert prescriber guidance to determine optimal treatment selection based on individual response and tolerability factors.
Wegovy 1.7mg Pricing vs Mounjaro Cost Comparison
Our Wegovy 1.7mg click chart pricing shows £139.99 per pen, positioned as the penultimate dose before maintenance therapy. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive rates. For seamless progression to maintenance, our Elevate Duo bundle combines 1.7mg and 2.4mg pens for £369.99, eliminating the need for separate orders and ensuring uninterrupted treatment continuity.
Mounjaro pricing follows a different structure reflecting its distinct dosing schedule, with comparable therapeutic stages priced competitively across our range. Both treatments require ongoing commitment, making our consistency bundles particularly valuable—the Consistency 1.7mg bundle provides two Wegovy pens for £309.99, ideal for patients who may need extended time at this dose level. All pricing includes next-day cold-chain delivery and comprehensive clinical support throughout your treatment journey.
Clinical Evidence: Wegovy 1.7mg Click Chart Effectiveness
The Wegovy 1.7mg click chart position corresponds to week 13-16 data from the pivotal STEP trials, where patients demonstrated progressive weight reduction as they approached maintenance dosing. In the STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with significant results evident by the 1.7mg dose stage. The dose escalation protocol ensures optimal tolerability while maximising therapeutic benefit.
Comparative clinical data shows both Wegovy and Mounjaro demonstrate substantial efficacy in clinical trials, though direct head-to-head comparisons are limited due to different trial designs. The 1.7mg Wegovy dose represents 68% of the maintenance dose strength, where appetite suppression and satiety effects typically plateau before the final dose escalation. EverydayMeds prescribers review individual progress at each dose level to optimise treatment outcomes.
How Wegovy 1.7mg Works: GLP-1 Mechanism
Wegovy's 1.7mg click chart dosing leverages semaglutide's GLP-1 receptor agonist mechanism to reduce appetite and promote satiety after smaller meals. The medication works on brain appetite centres, specifically the hypothalamus, to regulate food intake and reduce cravings for high-calorie foods. At the 1.7mg dose level, patients typically experience well-established appetite regulation with consistent meal satisfaction from reduced portions. The once-weekly injection maintains steady blood levels throughout the week, providing reliable appetite control without daily dosing requirements. This dose stage often represents the point where lifestyle changes become more sustainable due to reduced food preoccupation and improved eating behaviour patterns.
Ordering Your Wegovy 1.7mg Click Chart Treatment
Accessing Wegovy 1.7mg through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for prescription-only weight management treatment. Our GPhC-registered prescribers review applications within 3 working days (express 24-hour service available), assessing your medical history, current medications, and weight management goals. Once approved, your 1.7mg Wegovy pen ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. The FlexTouch pen includes clear dosing instructions and our clinical team remains available for ongoing support throughout your treatment journey. All orders include comprehensive patient information leaflets and access to our specialist weight management guidance resources.
Wegovy 1.7mg Storage and Practical Considerations
The Wegovy 1.7mg click chart includes important storage specifications that differentiate it from Mounjaro—Wegovy maintains potency for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Store unused pens in your fridge at 2-8°C, and once in use, the FlexTouch pen can remain at room temperature for convenient weekly dosing. Each pen contains exactly four weekly doses of 1.7mg, lasting one month when administered as directed. The pen's click mechanism provides tactile and audible confirmation of dose delivery, with a clear dose counter showing remaining doses. Never freeze Wegovy pens, and protect from direct light and excessive heat during the 6-week room temperature storage period.
Wegovy 1.7mg vs Mounjaro: Advanced Treatment Planning
At the Wegovy 1.7mg click chart stage, treatment planning becomes crucial as you approach maintenance therapy within 4 weeks. Many patients use this dose period to evaluate long-term treatment sustainability, medication tolerance, and results optimisation before committing to ongoing 2.4mg maintenance. Mounjaro's equivalent planning stage occurs around 7.5mg dosing, where similar assessment of progress and tolerability guides future treatment decisions.
EverydayMeds patients frequently transition from Wegovy 1.7mg using our Elevate Duo bundle, ensuring seamless progression to 2.4mg maintenance without treatment interruption. Alternatively, some prescribers recommend extended time at 1.7mg for tolerance optimisation before final escalation. Both Wegovy and Mounjaro remain available through our clinical team, allowing treatment switches if individual response or side effect profiles warrant alternative approaches to weight management therapy.
Complete Your Wegovy 1.7mg Click Chart Order Today
Ready to continue your Wegovy journey with 1.7mg dosing or compare with Mounjaro alternatives? Visit https://everydaymeds.co.uk/collections/weight-loss to access both treatments through our streamlined clinical assessment process. New customers use code FIRST40 at checkout, while returning customers apply DOSE25 for optimal pricing on your Wegovy 1.7mg prescription. Our Elevate Duo bundle provides seamless transition planning, or choose individual pens for maximum flexibility in your treatment approach. All orders benefit from our expert clinical support, next-day delivery, and comprehensive treatment guidance from our GPhC-registered pharmacy team (#9012878). Begin your clinical assessment now and receive your Wegovy 1.7mg click chart treatment with complete confidence in our prescription-only medicine service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026